Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients

NCT02282709 is registered in ClinicalTrials.gov with Foundation for Liver Research as lead sponsor.

NCT NCT02282709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02282709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients
Lead sponsor
Foundation for Liver Research
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2015
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c